Barnett / Grice New Mechanisms in Glucose Control

1. Auflage 2013
ISBN: 978-1-118-68218-0
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 72 Seiten, E-Book

New Mechanisms in Glucose Control presents a clear overviewof the new drugs and treatment therapies that have been developedin recent years to help improve glycaemic management forthe diabetic patient, namely the incretin mimetics (GLP-1 agonists)and DPP-4 inhibitors. It also considers other drug classescurrently in development and undergoing clinical trials includingthe SGLT2 inhibitors and other pipeline products. In addition topharma cotherapeutic agents, the role of bariatric as a managementtool for diabetes is covered as well as consideration of theorganisation of diabetes care with a community focus.
This indispensable pocketbook details the newer treatments andoffers a comparison with more traditional agents includingsulphonyureas, glitazones and insulin. The pros and cons oftraditional therapies are discussed as well as the epidemiology andpathogenesis of type 2 diabetes, helping to give the reader abetter understanding of the disease area and itsmanagement.
New Mechanisms in Glucose Control is essential readingfor health professionals working in primary or secondary care andinvolved in treating diabetic patients.

Autoren/Hrsg.

Barnett, Anthony H.

Barnett, Tony

Grice, Jenny

Inhaltsverzeichnis

1 Epidemiology and pathogenesis of type 2 diabetes.
2 Overview of current diabetes management.
3 The incretin system.
4 The incretin mimetics.
5 The dipeptidyl peptidase 4 inhibitors.
6 Sodium-glucose cotransporter-2 inhibitors.
7 Pipeline diabetes therapies.
8 Bariatric surgery for the treatment of type 2 diabetes.
9 Organisation of diabetes care.
Index.

Über Autor(innen)

Anthony Barnett, Diabetes Centre, Birmingham HeartlandsHospital, Birmingham, UK
Jenny Grice, Medical Writer, France